Related Experiment Video
Updated: Jan 9, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
A large language model for clinical outcome adjudication from telephone follow-up interviews: a secondary analysis of
Zhao Shi1, Bingqian Wu2, Bin Hu1
1Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Abstract:
Automated adjudication of clinical outcomes from telephone follow-ups is crucial for reducing workload and increasing data quality in large-scale trials. Here, we show that a domain-specific large language model (Fu-LLM) effectively automates the preadjudication of key clinical events-including death, hospitalization, and medication use-based on 1,046 vignettes of follow-up telephone interviews conducted across three centers in a randomized clinical trial (China CT-FFR Study 3). Fu-LLM outperforms not only state-of-the-art general-purpose LLMs (e.g. GPT-3.5-turbo, GPT-4o, DeepSeek-v3, Claude 3.5-Sonnet, and Gemini-2.0-Pro) and conventional machine learning models (Support Vector Machine), but also human adjudicators in a silico human-model comparative study. It also shows greater robustness than different versions of GPT-4 do in temporal drift tests. Our findings demonstrate that Fu-LLM can significantly streamline outcome identification in clinical trials, offering a scalable and accurate tool for automating labour-intensive adjudication processes.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Comparing the Survival Analysis of Two or More Groups
Cancer Survival Analysis

